Instituto de Biomedicina de Sevilla (Hospital Universitario Virgen del Rocío/ CSIC/ Universidad de Sevilla), 41013 Seville, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
Med Mycol. 2021 Sep 3;59(9):849-854. doi: 10.1093/mmy/myab010.
We conducted a pilot study of patients with cystic fibrosis (CF) to assess intra-family transmission of P. jirovecii and compare it with data on other prevalent pathogens such as P. aeruginosa and S. pneumoniae, in which respiratory transmission has already been documented. Oral swab samples from 10 patients with CF and 15 household members were collected at baseline and 2 weeks later. P. aeruginosa and S. pneumoniae were assessed using standardized culture methods and PCR, and P. jirovecii was assessed using real and nested PCR, genotyping the positive samples by direct sequencing. P. aeruginosa cultures were positive for 7/10 (70%) of patients with CF at baseline and was identified by PCR in 8/10 (80%) of cases at baseline and 2 weeks later. S. pneumoniae cultures were negative for all patients, but the microorganism was identified by PCR in two cases. P. jirovecii was detected by real time and nested PCR in 5/10 (50%) of the patients at the two time points. In the household members, P. aeruginosa and P. jirovecii were identified in 7/15 (46.7%), and S. pneumoniae was identified in 8/15 (53,3%). The concordance of positive or negative pairs of patients with CF and their household members was 33.3% (5/15) for P. aeruginosa, 46.7% (7/15) for S. pneumonia and 93.3% (14/15) for P. jirovecii. The concordance for P. jirovecii genotypes among five pairs with available genotype was 100%. This study suggests for the first time the possible transmission of Pneumocystis in the home of patients with CF, indicating that patients and their household members are reservoirs and possible sources of infection.
This study suggests for the first time the possible transmission of Pneumocystis in the family environment of patients with cystic fibrosis, indicating that patients and their household members are reservoirs and possible sources of this infection.
我们对囊性纤维化 (CF) 患者进行了一项试点研究,以评估卡氏肺孢子菌在家庭内的传播,并将其与其他已证实存在呼吸道传播的常见病原体(如铜绿假单胞菌和肺炎链球菌)的数据进行比较。从 10 名 CF 患者和 15 名家庭成员收集了基线和 2 周后的口腔拭子样本。使用标准化培养方法和 PCR 评估铜绿假单胞菌和肺炎链球菌,使用实时和巢式 PCR 评估卡氏肺孢子菌,并对阳性样本进行直接测序进行基因分型。7/10(70%)的 CF 患者基线时的卡氏肺孢子菌培养阳性,8/10(80%)的病例基线时和 2 周后 PCR 阳性。所有患者的肺炎链球菌培养均为阴性,但有 2 例通过 PCR 鉴定。在两个时间点,5/10(50%)的患者通过实时和巢式 PCR 检测到卡氏肺孢子菌。在家庭成员中,15/15(100%)的人检测到铜绿假单胞菌和卡氏肺孢子菌,15/15(100%)的人检测到肺炎链球菌。CF 患者及其家庭成员的阳性或阴性配对的一致性为 33.3%(5/15)的铜绿假单胞菌,46.7%(7/15)的肺炎链球菌和 93.3%(14/15)的卡氏肺孢子菌。5 对具有可用基因型的患者中卡氏肺孢子菌基因型的一致性为 100%。本研究首次提示 CF 患者家庭中卡氏肺孢子菌的传播可能,表明患者及其家庭成员是该感染的储主和可能的传染源。
本研究首次提示 CF 患者家庭环境中卡氏肺孢子菌的传播可能,表明患者及其家庭成员是该感染的储主和可能的传染源。